Flash FinanceUS
Market open S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · PETMED EXPRESS INC (PETS)

PetMeds names Jeff Willard CEO and president, effective September 28, 2026

Neutral Impact 4 of 5 leadership Written later

PetMed Express (PetMeds) appointed Jeff Willard as Chief Executive Officer, President and a director, effective September 28, 2026, succeeding Leslie C.G. Campbell, who has served as Interim CEO and President since August 2025. Campbell is also retiring as Board Chair and leaving the Board on the same date, and Justin Mennen will become Chair. The filing sets Willard's initial base salary at $550,000 and a three-year initial employment term, a significant change in the company's top leadership.

Key points

  • Jeff Willard, age 56, was CEO of Stewart-MacDonald from November 2024 to September 2026; the Board approved his appointment on August 27, 2026.
  • Initial base salary of $550,000, target annual bonus of 75% of base salary, and a $120,000 signing bonus.
  • Justin Mennen, currently Lead Independent Director, succeeds Leslie C.G. Campbell as Chair effective September 28, 2026.
  • Campbell will remain as a full-time Strategic Advisor for 60 days following Willard's arrival.

The filing

CompanyPETMED EXPRESS INC (PETS)
Form8-K, current report
Filed with the SECSep 17, 2026, 9:08 AM ET
Accession number0001040130-26-000045

Items reported: 5.02 Director / Officer Change7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 8:29 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on September 17, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.